Celgene Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference | Financial Buzz

Celgene Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference

Celgene Corporation (NASDAQ:CELG) will present a business update and
provide 2019 financial guidance at the 37th Annual J.P.
Morgan Healthcare Conference on January 7, 2019 at 7:30 a.m. PT/ 10:30
a.m. ET. The presentation and breakout session can be accessed live by
webcast and will be made available in the Investor Relations section of
the Company’s website at www.celgene.com.

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in the
discovery, development and commercialization of innovative therapies for
the treatment of cancer and inflammatory diseases through
next-generation solutions in protein homeostasis, immuno-oncology,
epigenetics, immunology and neuro-inflammation. For more information,
please visit www.celgene.com.
Follow Celgene on Social Media: @Celgene,
and YouTube.

Forward-Looking Statements

This press release contains forward-looking statements, which are
generally statements that are not historical facts. Forward-looking
statements can be identified by the words “expects,” “anticipates,”
“believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and
similar expressions. Forward-looking statements are based on
management’s current plans, estimates, assumptions and projections, and
speak only as of the date they are made. We undertake no obligation to
update any forward-looking statement in light of new information or
future events, except as otherwise required by law. Forward-looking
statements involve inherent risks and uncertainties, most of which are
difficult to predict and are generally beyond our control. Actual
results or outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of
factors, many of which are discussed in more detail in our Annual Report
on Form 10-K and our other reports filed with the Securities and
Exchange Commission.

Hyperlinks are provided as a convenience and for informational
purposes only. Celgene bears no responsibility for the security or
content of external websites.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181218005459/en/